Lidoflazine
26 interactions 2 explained in plain English
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Arsenic Trioxide
Arsenic Trioxide Injection
Gemifloxacin
Chloroquine
Disopyramide
Mefloquine
Contraindicated
Lidoflazine Arsenic Trioxide Trisenox An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Arsenic Trioxide Injection Trisenox An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) DetailsMajor
Lidoflazine Amitriptyline Elavil Explained An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Chloroquine Aralen® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Disopyramide Norpace An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Dofetilide Tikosyn An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Dolasetron Anzemet An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Dolasetron Injection Anzemet An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Flecainide Tambocor® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Foscarnet Injection Foscavir An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Gemifloxacin Factive An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Isradipine DynaCirc® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Mefloquine Lariam® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Octreotide Bynfezia An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Lidoflazine Octreotide Injection Bynfezia An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) DetailsModerate
Lidoflazine Atenolol Tenormin Explained Hypotension, bradycardia, and AV conduction disturbances Details Lidoflazine Acebutolol Sectral® Hypotension, bradycardia, and AV conduction disturbances Details Lidoflazine Betaxolol Betoptic S Hypotension, bradycardia, and AV conduction disturbances Details Lidoflazine Betaxolol Ophthalmic Betoptic® Hypotension, bradycardia, and AV conduction disturbances Details Lidoflazine Bisoprolol Zebeta® Hypotension, bradycardia, and AV conduction disturbances Details Lidoflazine Esmolol Brevibloc Hypotension, bradycardia, and AV conduction disturbances Details Lidoflazine Labetalol Normodyne® Hypotension, bradycardia, and AV conduction disturbances Details Lidoflazine Levobunolol Ophthalmic AKBeta® Hypotension, bradycardia, and AV conduction disturbances Details Lidoflazine Nadolol Corgard Hypotension, bradycardia, and AV conduction disturbances Details Lidoflazine Nebivolol Bystolic Hypotension, bradycardia, and AV conduction disturbances Details Lidoflazine Penbutolol Levatol® Hypotension, bradycardia, and AV conduction disturbances DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.